Interleukin-2 (IL-2), Pegylated Interferon (PEG-IFN Alfa-2b), and Ribavirin (RBV) Treatment in Patients With Hepatitis C and HIV Coinfection
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Marshall GlesbyStudy Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ucla Care Center Crs
Los Angeles, California, United States
- University of Colorado Hospital Crs
Aurora, Colorado, United States
- Northwestern University Crs
Chicago, Illinois, United States
- Univ. of Iowa Healthcare, Div. of Infectious Diseases
Iowa City, Iowa, United States
- Johns Hopkins Adult Aids Crs
Baltimore, Maryland, United States
- Weill Med. College of Cornell Univ., the Cornell Ctu
New York, New York, United States
- Univ. of Cincinnati Crs
Cincinnati, Ohio, United States
- Univ. of Texas Southwestern Med. Ctr., Amelia Court Continuity Clinic
Dallas, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- —
- Primary completion
- —
- Completion
- 31 Mar 2005
- Last update posted
- 1 Nov 2021
- Registered enrollment
- 24
- Registry id
- NCT00015652
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.